The lawsuits will keep making headlines. Premiums will keep rising. Leadership will continue asking harder questions. But, the organizations best prepared for that future aren’t the ones that check the box.

Hiring is gaining momentum with 57% of small and mid-size business CEOs planning to increase headcount within the next 12 months.

The nation’s three primary insulin manufacturers (Eli Lilly, Novo Nordisk and Sanofi) and three largest PBMs (CVS Caremark, Express Script and OptumRx) are named in the lawsuit.

They are all at least 50, and a new Allianz Life survey report shows they're more nest-egg aware.